Table of Content

1. Market Definition & Scope
1.1. Market Definition
1.2. Market Coverage
1.3. Market Ecosystem
1.4. Currency and Limitations
1.5. Key Stakeholders

2. Research Methodology
2.1. Research Approach
2.2. Process of Data Collection and Validation
2.2.1. Secondary Research
2.2.2. Primary Research
2.3. Market Sizing and Forecasting
2.3.1. Market Estimation Approach
2.3.2. Growth Forecast Approach
2.4. Assumptions for the Study

3. Executive Summary

4. Market Insights
4.1. Overview
4.2. Key Factors Affecting Market Growth
4.2.1. Impact Analysis of DROC
4.2.1.1. Increasing Focus on Preventive Healthcare and Self-testing is Driving the Market
4.2.1.2. Data Privacy Concerns Associated with Digital Therapeutics Applications are Restraining Market Growth
4.2.1.3. Emerging Economies and Growing Product Pipeline is Providing Opportunities for Market Growth
4.2.1.4. Lengthy and Tedious Regulatory Approval Process is Posing a Challenge to the Market’s Growth
4.3. Trends
4.3.1. Partnership of Digital Therapeutics Companies with Pharmaceutical Companies
4.3.2. Integration of Artificial Intelligence (AI) in Digital Therapeutics
4.4. Regulatory and Reimbursement Approval Pathway
4.4.1. U.S.
4.4.2. Germany
4.4.3. France
4.4.4. Belgium
4.4.5. U.K.
4.4.6. China
4.4.7. Japan
4.4.8. South Korea
4.5. Case Study
4.5.1. Connected Inhalers to Reduce Asthma Symptoms (Propeller Health)
4.5.2. Sharp Rees-Stealy Medical Group (U.S.) Improves Outcomes with Diabetes Management Program
4.5.3. Improvement in Self-management of Diseases with Digital Health Solutions

5. Digital Therapeutics Market Assessment?by Type
5.1. Overview
5.2. Disease Management and Treatment DTx
5.3. Disease Prevention DTx

6. Digital Therapeutics Market Assessment?by Application
6.1. Overview
6.2. Mental Health
6.3. Diabetes
6.4. Cardiovascular Diseases
6.5. Gastrointestinal Disorders
6.6. Neurology
6.7. Rehabilitation & Patient Care
6.8. Respiratory Disorders
6.9. Oncology
6.10. Addiction Management
6.11. Sleep Disorders
6.12. Smoking Cessation
6.13. Other Applications

7. Digital Therapeutics Market Assessment?by End Users
7.1. Overview
7.2. Providers
7.3. Individual Consumers
7.4. Employers
7.5. Payers
7.6. Other End Users

8. Digital Therapeutics Market Assessment?by Geography
8.1. Overview
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.3. Europe
8.3.1. Germany
8.3.2. U.K.
8.3.3. France
8.3.4. Italy
8.3.5. Spain
8.3.6. Rest of Europe (RoE)
8.4. Asia-Pacific
8.4.1. China
8.4.2. Japan
8.4.3. India
8.4.4. Rest of Asia-Pacific (RoAPAC)
8.5. Latin America
8.5.1. Brazil
8.5.2. Mexico
8.5.3. Rest of Latin America (RoLATAM)
8.6. Middle East & Africa

9. Competition Analysis
9.1. Introduction
9.2. Key Growth Strategies
9.3. Competitive Benchmarking
9.4. Competitive Dashboard
9.4.1. Industry Leaders
9.4.2. Market Differentiators
9.4.3. Vanguards
9.4.4. Emerging Companies
9.5. Company Ranking for Global Digital Therapeutics Market (2022)

10. Company Profiles (Company Overview, Financial Snapshot, Product Portfolio, Strategic Developments, SWOT Analysis)
10.1. ResMed Inc.
10.2. Teladoc Health, Inc.
10.3. Noom, Inc.
10.4. DarioHealth Corp.
10.5. GAIA AG
10.6. Biofourmis Inc.
10.7. Virta Health Corp.
10.8. Welldoc, Inc.
10.9. Glooko, Inc.
10.10. 2Morrow Inc.
10.11. Canary Health
10.12. BigHealth
10.13. Akili, Inc.
10.14. Limbix Health, Inc.
10.15. Kaia Healthcare Software Inc.
10.16. Popular Mentions

11. Appendix
11.1. Available Customization
11.2. Related Reports



List of Figures

List of Figures
Figure 1 Market Ecosystem
Figure 2 Key Stakeholders
Figure 3 Research Process
Figure 4 Secondary Sources Referenced for this Study
Figure 5 Primary Research Techniques
Figure 6 Key Executives Interviewed
Figure 7 Breakdown of Primary Interviews (Supply-Side & Demand Side)
Figure 8 Market Sizing and Growth Forecast Approach
Figure 9 Global Digital Therapeutics Market Size, by Type, 2023 Vs. 2030 (USD Million)
Figure 10 Global Digital Therapeutics Market Size, by Application, 2023 Vs. 2030 (USD Million)
Figure 11 Global Digital Therapeutics Market Size, by End User, 2023 Vs. 2030 (USD Million)
Figure 12 Global Digital Therapeutics Market, by Geography
Figure 13 Global Digital Therapeutics Market: Impact Analysis
Figure 14 Germany: Reimbursement Approval Pathway
Figure 15 Global Digital Therapeutics Market, by Type, 2023 Vs. 2030 (USD Million)
Figure 16 Global Digital Therapeutics Market, by Applications, 2023 Vs. 2030 (USD Million)
Figure 17 Diabetes Patients, by Region 2021 Vs. 2030 Vs. 2045 (Million)
Figure 18 Drug Consumption Among the Population in 2020 (Million People)
Figure 19 Prevalence of Tobacco Use (% Of Adults) in 2020
Figure 20 Global Digital Therapeutics Market Size, by End User, 2023 Vs. 2030 (USD Million)
Figure 21 Digital Therapeutics Market, by Region, 2023 Vs. 2030 (USD Million)
Figure 22 North America: Digital Therapeutics Market Snapshot
Figure 23 U.S.: Number of People with Chronic Diseases, 2005-2030 (In Millions)
Figure 24 Europe: Digital Therapeutics Market Snapshot
Figure 25 Asia-Pacific: Digital Therapeutics Market Snapshot
Figure 26 Japan: Growth in Aging Population 2015-2021 (Million)
Figure 27 RoAPAC: Growth in Aging Population 2015 Vs. 2017 Vs. 2021 (Million)
Figure 28 Latin America: Digital Therapeutics Market Snapshot
Figure 29 Growth in the Elderly Population 2021 Vs. 2017 Vs. 2015
Figure 30 Key Growth Strategies Adopted by Leading Players, 2020–2023
Figure 31 Digital Therapeutics Market: Competitive Benchmarking (Based on Type)
Figure 32 Competitive Benchmarking for DTx: Based on DTx Capabilities and Therapeutic Area
Figure 33 Competitive Dashboard: Digital Therapeutics Market
Figure 34 Company Ranking: Digital Therapeutics Market (2022)
Figure 35 Resmed Inc.: Financial Snapshot (2022)
Figure 36 Teladoc Health, Inc.: Financial Overview (2022)
Figure 37 Dariohealth Corp.: Financial Snapshot (2022)
Figure 38 Akili, Inc.: Financial Snapshot (2022)